Literature DB >> 10823569

Nosocomial Candida guilliermondii fungemia in cancer patients.

M Mardani1, H A Hanna, E Girgawy, I Raad.   

Abstract

From 1988 to 1998, we identified nine patients with Candida guilliermondii fungemia. Four of the five patients with nosocomial infection died, while all of the non-nosocomial cases survived, even though one half of them (2/4) did not receive any treatment Nosocomial C guilliermondii fungemia is often associated with poor outcome despite aggressive antifungal therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10823569     DOI: 10.1086/501768

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

Review 1.  Coevolution of morphology and virulence in Candida species.

Authors:  Delma S Thompson; Patricia L Carlisle; David Kadosh
Journal:  Eukaryot Cell       Date:  2011-07-15

2.  Candida guilliermondii fungemia in patients with hematologic malignancies.

Authors:  Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 4.  Uncommon opportunistic fungal infections of oral cavity: A review.

Authors:  Ag Deepa; Bindu J Nair; Tt Sivakumar; Anna P Joseph
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

5.  Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.

Authors:  Dong Sik Jung; Dimitrios Farmakiotis; Ying Jiang; Jeffrey J Tarrand; Dimitrios P Kontoyiannis
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.